Myriad Genetics settles Vectra test qui tam case for $48M ($45.25M to govt, $2.75M to relator)

MYRIAD GENETICS INC

Total settlement of $48 million: $45.25M to United States and California, $2.75M to Relator's counsel.
No admission of liability; company expressly denies allegations in the lawsuit.
DOJ and State of California declined to intervene after investigation.
Lawsuit dismissed with prejudice as to Relator and California; federal claims dismissed without prejudice.
Settlement resolves claims concerning Crescendo's former Vectra test dating back to 2010.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.